Modernizing Pharmaceutical Manufacturing
Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-02-02-2002
Volume 26
Issue 2
FDA's Center for Drug Evaluation and Research is driving efforts toward creating initiatives to streamline regulatory processes, speed up drug production, and reduce costs.
Articles in this issue
Using Earned-Value Analysis to Better Manage Projects
Microbial Bioburden on Oral Solid Dosage Forms
Overview of Technologies Supporting Security Requirements in 21 CFR Part 11, Part I
Modernizing Pharmaceutical Manufacturing
The Role of Computational Fluid Dynamics in the Pharmaceutical Industry
Available Guidance and Best Practices for Conducting Forced Degradation Studies
Outsourcing Outlook
Effect of Formulation and Process Variables on Matrix Erosion and Drug Release from a Multiunit Erosion Matrix of a Poorly Soluble Drug
Recent Videos
Related Content
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025Article
The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
